Two primary doses of diphtheria-tetanus-acellular pertussis vaccine induce immunological responses to Bordetella pertussis as strong as those induced by three primary doses

Vaccine

Volumn 15, Issue 17-18, 1997, Pages 1955-1958

  Tomoda, Takashi ^a   Ogura, Hideo ^a   Kurashige, Takanobu ^a  

^a National Hospital Organization Kochi National Hospital   (Japan)

Author keywords

Diphtheria tetanus acellular pertussis vaccine; Filamentous hemagglutinin; Two primary doses

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEMAGGLUTININ; PERTUSSIS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BORDETELLA PERTUSSIS; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PERTUSSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

ADHESINS, BACTERIAL; ADOLESCENT; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMAGGLUTININS; HUMANS; IMMUNIZATION SCHEDULE; INFANT; LEUKOCYTES, MONONUCLEAR; MALE; VIRULENCE FACTORS, BORDETELLA;

EID: 0030733651     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00122-9     Document Type: Article

References (13)

1. Sato, Y., Kimura, M. and Fukumi, H. Development of a pertussis component vaccine in Japan. Lancet 1984, 1, 122-126.
2. Aoyama, T., Hagiwara, S., Murase, Y., Kato, T. and Iwata, T. Adverse reactions and antibody responses to acellular pertussis vaccine. Journal of Pediatrics 1986, 108, 925-930.
3. Zackrisson, G., Arminjon, F. and Krantz, I. et al. Serum antibody response to filamentous hemagglutinin in patient with clinical pertussis measured by enzyme-linked immunosorbent assay. European Journal of Microbiology of Infectious Diseases 1988, 7, 764-770.
4. Steketee, R. W., Burstyn, D. G. and Wassilak, S. G. et al. A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. Journal of Infectious Diseases 1988, 157, 441-449.
5. Thomas, M. G., Redhead, K. and Lambert, H. P. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination. Journal of Infectious Diseases 1989, 159, 211-218.
6. Gearing, A. J. H., Bird, C., Wadha, M. and Redhead, K. The primary and secondary cellular immune responses to whole cell Bordetella pertussis vaccine and its component. Clinical and Experimental Immunology 1987, 68, 275-281.
7. De Magistris, M. T., Romano, M., Nuti, S., Rappuoli, R. and Tagliabue, A. Dissecting human T cell responses against Bordetella pertussis. Journal of Experimental Medicine 1988, 168, 1351-1362.
8. Tomoda, T., Ogura, H. and Kurashige, T. Immune responses to Bordetella pertussis infection and vaccination. Journal of Infectious Diseases 1991, 163, 559-563.
9. Sato, Y., Cowell, J. L., Sato, H., Burstyn, D. G. and Manclark, C. R. Separation and purification of the hemagglutinins from Bordetella pertussis. Infection and Immunity 1983, 41, 313-320.
10. Blackwelder, W. C., Storsaeter, J., Olin, P. and Hallander, M. D. Acellular pertussis vaccines - Efficacy and evaluation of clinical case definitions. A.J.D.C. 1991, 145, 1285-1289.
11. Blennow, M., Gransstrom, M., Jaatmaa, E. and Olin, P. Primaryu immunization of infants with an acellular pertussis vaccine in a double-blind randomized clinical trial. Pediatrics 1988, 82, 293-299.
12. Tomoda, T., Ogura, H. and Kurashige, T. The longevity of the immune response to filamentous hemagglutinin and pertussis toxin in patients with pertussis in a semiclosed community. Journal of Infectious Diseases 1992, 166, 908-910.
13. Sato, Y. and Sato, H. Further characterization of Japanese acellular pertussis vaccine in 1988 by 6 Japanese manufacturers. Tokai Journal of Experimental and Clinical Medicine 1988, 13, 79-88.